Skip to main content Accessibility help
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 12
  • Print publication year: 2007
  • Online publication date: December 2009

32 - HSV-1 AND 2: Pathogenesis and disease

from Part III - Pathogenesis, clinical disease, host response, and epidemiology: HSV-1 and HSV-2



The transmission of herpes simplex virus (HSV) infection is dependent upon intimate, personal contact of a susceptible seronegative individual with someone excreting HSV. Virus must come in contact with mucosal surfaces or abraded skin for infection to be initiated. With viral replication at the site of primary infection, either an intact virion or, more simply, the capsid is transported retrograde by neurons to the dorsal root ganglia where, after another round of viral replication, latency is established (Fig. 32.1(a), left panel). The more severe the primary infection, as reflected by the size, number, and extent of lesions, the more likely it is that recurrences will ensue. Although replication sometimes leads to disease and, infrequently, results in life-threatening infection (e.g., encephalitis), the host-virus interaction leading to latency predominates. After latency is established, a proper stimulus causes reactivation; virus becomes evident at mucocutaneous sites, appearing as skin vesicles or mucosal ulcers (Fig. 32.1(b), right panel).

Infection with HSV-1 generally occurs in the oropharyngeal mucosa. The trigeminal ganglion becomes colonized and harbors latent virus. However, it has been increasingly common to detect evidence of HSV-1 in the genital tract, usually the consequence of oral-genital sex. When such occurs, recurrences of HSV-1 in the genital tract are uncommon. Acquisition of HSV-2 infection is usually the consequence of transmission by genital contact. Virus replicates in the genital, perigenital or anal skin sites with seeding of the sacral ganglia (Fig. 32.2).

Bader, C., Crumpacker, C. S., Schnipper, L. al. (1978). The natural history of recurrent facial–oral infection with herpes simplex virus. J. Infect. Dis., 138, 897–905.
Baringer, J. R. and Swoveland, P. (1973). Recovery of herpes simplex virus from human trigeminal ganglions. N. Engl. J. Med., 288, 648–650.
Bastian, F. O., Rabson, A. S., and Yee, C. L. (1972). Herpesvirus hominis: Isolation from human trigeminal ganglion. Science, 178, 306.
Becker, T. M., Kodsi, R., Bailey, P., Lee, F., Levandowski, R., and Nahmias, A. J. (1988). Grappling with herpes: herpes gladiatorum. Am. J. Sports Med., 16, 665–669.
Bernstein, D. I., Garratty, E., Lovett, M. A., and Bryson, Y. J. (1985). Comparison of Western Blot analysis to microneutralization for the protection of type-specific herpes simplex virus antibodies. J. Med. Virol., 15, 223–230.
Belongia, E. A., Goodman, J. L., Holand, E. al. (1991). An outbreak of herpes gladiatorum at a high school wrestling camp. N. Engl. J. Med., 325, 906–910.
Boos, J. and Esiri, M. M. (1986). Sporadic encephalitis I. Viral Encephalitis: Pathology, Diagnosis and Management. Oxford, UK: Blackwell Scientific Publishers, 55–93.
Boos, J. and Kim, J. H. (1984). Biopsy histopathology in herpes simplex encephalitis and in encephalitis of undefined etiology. Yale J. Biol. Med., 57, 751–755.
Brown, Z. A., Benedetti, J., Ashley, al. (1991). Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor. N. Engl. J. Med., 324, 1247–1252.
Buchman, T. G., Roizman, B., Adams, G., and Stover, B. H. (1978). Restriction endonuclease fingerprinting of herpes simplex DNA: a novel epidemiological tool applied to a nosocomial outbreak. J. Infect. Dis., 138, 488–498.
Carton, C. A. and Kilbourne, E. D. (1952). Activation of latent herpes simplex by trigeminal sensory-root section. N. Engl. J. Med., 246, 172–176.
Cesario, T. C., Poland, J. D., Wulff, H., Chin, T. D., and Wenner, H. A. (1969). Six years experiences with herpes simplex virus in a children's home. Am. J. Epidemiol., 90, 416–422.
Chou, J. and Roizman, B. (1986). The terminal sequence of the herpes simplex virus genome contains the promoter of a gene located in the repeat sequences of the L component. J. Virol., 57, 629–637.
Chou, J., Kern, E. R., Whitley, R. J., and Roizman, B. (1990). Mapping of herpes simplex virus-1 neurovirulence to gamma134.5, a gene nonessential for growth in culture. Science, 250, 1262–1266.
Corey, L., Reeves, W. C., and Holmes, K. K. (1978). Cellular immune response in genital herpes simplex virus infection. N. Engl. J. Med., 299, 986–991.
Corey, L., Adams, H. G., Brown, Z. A., and Holmes, K. K. (1983). Genital herpes simplex virus infections: clinical manifestations, course and complications. Ann. Intern. Med., 98, 958–972.
Cushing, H. (1905). Surgical aspects of major neuralgia of trigeminal nerve: report of 20 cases of operation upon the Gasserian ganglion with anatomic and physiologic notes on the consequences of its removal. J. Am. Med. Assoc., 44, 3773–3379, 860–865, 920–929, 1002–1008.
Eberle, R., Russell, R. G., and Rouse, B. T. (1981). Cell-mediated immunity to herpes simplex virus: recognition of type-specific and type-common surface antigens by cytotoxic T cell populations. Infect. Immun., 34, 795–803.
Feder, H. M. Jr. and Long, S. S. (1983). Herpetic whitlow. Epidemiology, clinical characteristics, diagnosis, and treatment. Am. J. Dis. Child., 137, 861–863.
Garcia, J. H., Colon, L. E., Whitley, R. J., Kichara, J., and Holmes, F. J. (1984). Diagnosis of viral encephalitis by brain biopsy. Semin. Diagn. Pathol., 1, 71–80.
Goodpasture, E. W. (1929). Herpetic infections with special reference to involvement of the nervous system. Medicine, 8, 223–243.
Hesselgesser, J. and Horuk, R. (1999). Chemokine and chemokine receptor expression in the central nervous system. J. Neurovirol., 5, 13–26.
Hutto, C., Arvin, A., Jacobs, al. (1987). Intrauterine herpes simplex virus infections. J. Pediatr., 110, 97–101.
Jenson, H. B. and Shapiro, E. D. (1987). Primary herpes simplex virus infection of a diaper rash. Pediatr. Infect. Dis. J., 6, 1136–1138.
Kapur, N., Barker, S., Burrows, E. al. (1994) Herpes simplex encephalitis: long term magnetic resonance imaging and neuropsychological profile. J. Neurol. Neurosurg. Psychiatry, 57, 1334–1342.
Kimberlin, D. W., Lin, C.-Y., Jacobs, R. al. (2001). Natural history of neonatal herpes simplex virus infections in the acyclovir era. Pediatrics, 108, 223–229.
Kohl, S., West, M. S., Prober, C. G., Sullender, W. M., Loo, L. S., and Arvin, A. M. (1989). Neonatal antibody-dependent cellular cytoxic antibody levels are associated with the clinical presentation of neonatal herpes simplex virus infection. J. Infect. Dis., 160, 770–776.
Koskiniemi, M., Vaheri, A., and Taskinen, E. (1984). Cerebrospinal fluid alterations in herpes simplex virus encephalitis. Rev. Infect. Dis., 6, 608–618.
Kuzushima, K., Kimura, H., Kino, al. (1991). Clinical manifestations of primary herpes simplex virus type 1 infection in a closed community. Pediatrics, 87, 152–158.
Lakeman, F. D., Whitley, R. J., and the National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group., (1995). Diagnosis of herpes simplex encephalitis: Application of polymerase chain reaction to cerebrospinal fluid from brain biopsied patients and correlation with disease. J. Infect. Dis., 172, 857–863.
Lopez, C., Arvin, A. M., and Ashley, R., (1993). Immunity to herpesvirus infections in humans. In The Human Herpesviruses, ed. Roizman, B., Whitley, R. J., and Lopez, C.. New York: Raven Press, 397–425.
Lowhagen, G. B., Bonde, E., Eriksson, B., Nordin, L., Tunback, P., and Krantz, I. (2002). Self-reported herpes labialis in a Swedish population. Scand. J. Infect. Dis., 34, 664–667.
McMill, S. N. and Cartotto, R. C. (2000). Herpes simplex virus infection in a pediatric burn patient: case report and review. Burns, 26, 194–199.
McMillan, J. A., Weiner, L. B., Higgins, A. M., and Lamparella, V. J. (1993). Pharyngitis associated with herpes simplex virus in college students. Pediatr. Infect. Dis., 12, 280–284.
Martin, S., Courtney, R., Fowler, G., and Rouse, B. T. (1988). Herpes simplex virus type 1 specific cytotoxic T lymphocytes recognize virus structure proteins. J. Virol., 62, 2265–2273.
Mertz, G. J., Benedetti, J., Ashley, R., Selke, S., and Corey, L. (1992). Risk factors for the sexual transmission of genital herpes. Ann. Intern. Med., 116, 197–202.
Nahmias, A. J. and Roizman, B. (1973). Infection with herpes simplex viruses 1 and 2. N. Engl. J. Med., 289, 667–674; 719–725; 781–789.
Nash, A. A., Phelan, J., and Wildy, P. (1981). Cell-mediated immunity to herpes simplex virus-infected mice: H-2 mapping of the delayed-type hypersensitivity response and the antiviral T-cell response. J. Immunol., 126, 1260–1262.
Openshaw, H. and Bennett, H. E. (1982). Recurrence of herpes simplex virus after dental extraction. J. Infect. Dis., 146, 707.
Orton, P., Huff, J. C., Tonnesen, M. G., and Weston, W. L. (1984). Detection of herpes simplex viral antigen in skin lesions of erythema multiforme. Ann. Intern. Med., 101, 48–50.
Pavan-Langston, D. R., (1990). Major ocular viral diseases. In Antiviral Agents and Viral Diseases of Man. 3rd edn, ed. Galasso, G., Whitley, R. J., and Merigan, T.. New York: Raven Press, 183–233.
Pazin, G. J., Ho, M., and Jannetta, P. J. (1978). Reactivation of herpes simplex virus after decompression of the trigeminal nerve root. J. Infect. Dis., 138, 405–409.
Prober, C. G., Sullender, W. M., Yasukawa, L. L., Au, D. S., Yeager, A. S., and Arvin, A. M. (1987). Low risk of herpes simplex virus infections in neonates exposed to the virus at the time of vaginal delivery to mothers with recurrent genital herpes simplex virus infections. N. Engl. J. Med., 316, 240–244.
Rand, K. H., Rasmussen, L. E., Pollard, R. B., Arvin, A. M., and Merigan, T. C. (1977). Cellular immunity and herpes virus infections in cardiac transplant patients. N. Engl. J. Med., 296, 1372–1377.
Rasmussen, L. and Merigan, T. C. (1978). Role of T-lymphocytes in cellular immune responses during herpes simplex virus infection in humans. Proc. Natl Acad. Sci. USA, 75, 3957–3961.
Roizman, B. and Knipe, D. M., (2001). Herpes simplex viruses and their replication. In Fields' Virology. 4th edn, ed. Knipe, D. M., and Howley, R. M.. Philadelphia: Lippincott Williams & Wilkins, 2399–2459.
Roizman, B. and Pellett, P. E., (2001). Herpesviridae. In Fields' Virology. 4th edn. ed. Knipe, D. M. and Howley, R. M.. Philadelphia: Lippincott Williams & Wilkins, 2381–2397.
Roizman, B. and Sears, A. (1987). An Inquiry into the mechanisms of herpes simplex virus latency. Annu. Rev. Microbiol., 41, 543–571.
Russell, A. S. (1974). Cell-mediated immunity to herpes simplex virus in man. J. Infect. Dis., 129, 142–146.
Schmutzhard, E. S. (2001). Viral infections of the CNS with special emphasis on herpes simplex infections. J. Neurol., 248, 469–477.
Scott, D. A., Coulter, W. A., and Lamey, P. J. (1997). Oral shedding of herpes simplex virus type 1: a review. J. Oral Pathol. Med., 26, 441–447.
Selling, B. and Kibrick, S. (1964) An outbreak of herpes simplex among wrestlers (herpes gladiatorum). N. Engl. J. Med., 270, 979–982.
Simmons, A. (2002). Clinical manifestations and treatment considerations of herpes simplex virus infections. J. Infect. Dis., 186(Suppl. 1): S71–S77.
Spruance, S. L., Overall, J. C. Jr., Kern, E. R., Krueger, G. G., Pliam, V., and Miller, W. (1977). The natural history of recurrent herpes simplex labialis – implications for antiviral therapy. N. Engl. J. Med., 297, 69–75.
Stacey, A. and Atkins, B. (2000). Infectious diseases in rugby players: incidence, treatment and prevention. Sports Med., 29, 211–220.
Stevens, J. G. and Cook, M. L. (1971). Latent herpes simplex virus in spinal ganglia. Science, 173, 843–845.
Sullender, W. M., Miller, J. L., Yasukawa, L. al. (1987). Humoral and cell-mediated immunity in neonates with herpes simplex virus infection. J. Infect. Dis., 155, 28–37.
Tang, Y.-W., Mitchell, P. S., Espy, M. J., Smith, T. F., and Persing, D. H. (1999). Molecular diagnosis of herpes simplex virus infections in the central nervous system. J. Clin. Microbiol., 37, 2127–2136.
Wald, A., Corey, L., Cone, R., Hobson, A., Davis, G., and Zeh, J. (1997). Frequent genital herpes simplex virus 2 shedding in immunocompetent women: effect of acyclovir treatment. J. Clin. Investig., 99, 1092–1097.
Wheeler, C. E. Jr. and Abele, D. C. (1966). Eczema herpeticum, primary and recurrent. Arch. Dermatol., 93, 162–173.
Whitley, R. J., (2001). Herpes simplex virus. In Fields' Virology, 4th edn, ed. Knipe, D. M., Howley, R. M., Griffin, D., Lamb, R., Martin, M. and Straus, S. E.. New York: Lippincott Williams & Wilkins, 2461–2509.
Whitley, R. J., (2004). Herpes simplex virus. In Infections of the Central Nervous System, 3rd edn, ed. Scheld, W. M., Whitley, R. J., and Marra, C. M.. New York: Lippincott Williams & Wilkins, 123–144.
Whitley, R. J. and Roizman, B. (2001). Herpes simplex viruses. Lancet, 357, 1513–1518.
Whitley, R. J., Nahmias, A. J., Visitine, A. M., Fleming, C. L., Alford, C. A. Jr. and the National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group., (1980). The natural history of herpes simplex virus infection of mother and newborn. Pediatrics, 66, 489–494.
Whitley, R. J., Levin, M., Barton, al. (1984). Infections caused by herpes simplex virus in the immunocompromised host: natural history and topical acyclovir therapy. J. Infect. Dis., 150, 323–329.
Whitley, R. J., Corey, L., Arvin, al. (1988). Changing presentation of herpes simplex virus infection in neonates. J. Infect. Dis., 158, 109–116.
Whitley, R. J., Kern, E. R., Chatterjee, S., Chou, J., and Roizman, B. (1993). Replication, establishment of latency, and induced reactivation of herpes simplex virus γ134.5 deletion mutants in rodent models. J. Clin. Invest., 91, 2837–2843.
Whitley, R. J., Kimberlin, D. W., and Roizman, B. (1998). Herpes simplex virus. Clin. Infect. Dis., 26, 541–555.